Eton posts record Q3 revenue, raises 2026 guidance, advances rare disease pipelineNov 5PartnershipEton Pharmaceuticals, Inc.Updated
Eton licenses LIBERVANT buccal film from Aquestive for U.S. epilepsy marketOct 14M&AAquestive Therapeutics, Inc.Eton Pharmaceuticals, Inc.
Eton Pharmaceuticals posts 99% revenue growth, raises 2026 guidance to over $145 millionAug 13Quarterly updateEton Pharmaceuticals, Inc.
Eton licenses ASN-001 topical gel to expand infantile hemangioma portfolioAug 5M&AEton Pharmaceuticals, Inc.
Eton Pharmaceuticals names Danka Radosavljevic as Chief Operating OfficerAug 4PeopleEton Pharmaceuticals, Inc.
Eton Pharmaceuticals submits FDA supplement to expand KHINDIVI to younger childrenJul 29Regulatory decisionEton Pharmaceuticals, Inc.hydrocortisone